Education
About Us
Working with TipRanks
Follow Us
Myomo Inc (MYO)
:MYO
MYO Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.51 - $7.17
Previous CloseN/A
Volume192.17K
Average Volume (3M)542.59K
Market Cap
$184.97M
Enterprise Value$145.79M
Total Cash (Recent Filing)$24.37M
Total Debt (Recent Filing)$8.11M
Price to Earnings (P/E)―
Beta2.41
Next Earnings
May 07, 2025EPS Estimate
-0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.17
Shares Outstanding34,381,126
10 Day Avg. Volume1,030,318
30 Day Avg. Volume542,594
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)5.68
Price to Cash Flow (P/CF)13.70
P/FCF Ratio18.50
Enterprise Value/Market Cap0.79
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit6.29
Enterprise Value/Ebitda-24.23
Forecast
1Y Price Target
$8.81Price Target Upside63.75% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
Bulls Say, Bears Say
Bulls Say
EarningsMyomo reported record total revenues of $12.1M for the quarter, up 154% YoY and beating consensus estimate of $9.9M.
Financial PerformanceThe company achieved positive free cash flow of $2.5M in the quarter, another record for the company.
Growth StrategyThe company plans to double its advertising spend to $6M in 2025, which is expected to contribute significantly to new direct-to-patient sales.
Bears Say
Risks And ChallengesThere are risks related to commercial, clinical, financial, regulatory, and intellectual property challenges.
SpendingThe company plans to double its advertising spend to $6M in 2025, which could strain resources if results do not meet expectations.
---
Ownership Overview
16.18% Insiders
5.14% Mutual Funds
30.82% Other Institutional Investors
44.15% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
MYO FAQ
What was Myomo Inc’s price range in the past 12 months?
Myomo Inc lowest stock price was $2.51 and its highest was $7.17 in the past 12 months.
What is Myomo Inc’s market cap?
Myomo Inc’s market cap is $184.97M.
When is Myomo Inc’s upcoming earnings report date?
Myomo Inc’s upcoming earnings report date is May 07, 2025 which is in 44 days.
How were Myomo Inc’s earnings last quarter?
Myomo Inc released its earnings results on Mar 10, 2025. The company reported -$0.01 earnings per share for the quarter, beating the consensus estimate of -$0.023 by $0.013.
Is Myomo Inc overvalued?
According to Wall Street analysts Myomo Inc’s price is currently Undervalued.
Does Myomo Inc pay dividends?
Myomo Inc does not currently pay dividends.
What is Myomo Inc’s EPS estimate?
Myomo Inc’s EPS estimate is -0.08.
How many shares outstanding does Myomo Inc have?
Myomo Inc has 34,381,126 shares outstanding.
What happened to Myomo Inc’s price movement after its last earnings report?
Myomo Inc reported an EPS of -$0.01 in its last earnings report, beating expectations of -$0.023. Following the earnings report the stock price went up 40.767%.
Which hedge fund is a major shareholder of Myomo Inc?
Currently, no hedge funds are holding shares in MYO
---
Myomo Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$8.81 (63.75% Upside)
$8.81 (63.75% Upside)
Blogger Sentiment
Bullish
MYO Sentiment 70%
Sector Average 69%
Sector Average 69%
Insider Transactions
Sold Shares
Worth $383.0K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.5%
Last 30 Days ▼ 17.4%
Last 30 Days ▼ 17.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
49.03%
12-Months-Change
Fundamentals
Return on Equity
-36.69%
Trailing 12-Months
Asset Growth
189.71%
Trailing 12-Months
Company Description
Myomo Inc
Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.
---
MYO Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call presented a strong positive sentiment overall, with significant revenue growth, successful expansion into new markets, and improved financial metrics. However, challenges with Medicare Advantage and increased operating expenses are noted as areas of concern.Read More>---
MYO Stock 12 Month Forecast
Average Price Target
$8.81
▲(63.75% Upside)
Technical Analysis
Best Analysts Covering MYO
1 Year
1 Year Success Rate
8/9 ratings generated profit
1 Year Average Return
+167.70%
reiterated a buy rating 14 days ago
Copying Anthony Vendetti's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +167.70% per trade.
---